Prof. RNDr. Jaroslav Turánek, Dr.Sc. has his expertise in nanotechnology focused on drug delivery systems based on liposomes for construction of self-assembled vaccination nanoparticles and molecular-based adjuvants. He is pioneering the technologies of nanofibre-based mucoadhesive films for noninvasive mucosal vaccination and “printed vaccine technology”. Jaroslav Turánek has completed his PhD at the age of 27 years from Masaryk University Brno. He has published more than 80 papers on vaccines, drug targeting, anticancer and antimicrobial drugs in reputed journals. He is teaching immunology, biotechnology and immunochemistry at Masaryk University Brno and Technical University Brno. He is the president of Czech Society for Gene and Cell Therapy and Principal Investigator of vast multidisciplinar project OPVVV FIT “Pharmacology, Immunotherapy, nanoToxicology” focused on applicaton of complex nanotechnology and biotechnology approach for development of new modern vaccines and targeted drug delivery systems. At this time he works in NEXARS, a research organization which main mission is to carry out basic and applied research and experimental development and disseminate their results through teaching and education of students, publishing in renowned scientific journals and especially rapid transfer to practice. NEXARS is focused on research of the role of the microbiome for human health, development and preparation recombinant proteins for therapeutic and diagnostic purposes and development of biocompatible nanomaterials.
THE EUROBIOTECH JOURNAL (Active Now!)The EuroBiotech Journal is the official journal of European Biotechnology Thematic Network Association (EBTNA), an international journal for scientists who work in the field of biotechnology.